Attached files
| file | filename |
|---|---|
| EX-32 - EXHIBIT 32 - CALADRIUS BIOSCIENCES, INC. | clbs-ex32_20181231.htm |
| EX-31.2 - EXHIBIT 31.2 - CALADRIUS BIOSCIENCES, INC. | clbs-ex312_20181231xq4.htm |
| EX-31.1 - EXHIBIT 31.1 - CALADRIUS BIOSCIENCES, INC. | clbs-ex311_20181231xq4.htm |
| EX-21.1 - EXHIBIT 21.1 - CALADRIUS BIOSCIENCES, INC. | exh2112018.htm |
| EX-14.1 - EXHIBIT 14.1 - CALADRIUS BIOSCIENCES, INC. | exhibit141.htm |
| EX-10.1 - EXHIBIT 10.1 - CALADRIUS BIOSCIENCES, INC. | exhibit101directorcompensa.htm |
| 10-K - 10-K - CALADRIUS BIOSCIENCES, INC. | clbs-10kx20171231.htm |
Exhibit 23.1
CONSENT OF INDEPENENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 22, 2018, with respect to the consolidated financial statements included in the Annual Report of Caladrius Biosciences, Inc. on Form 10-K for the year ended December 31, 2017. We consent to the incorporation by reference of said report in the Registration Statements of Caladrius Biosciences, Inc. on Forms S-3 (File No. 333-196702, File No. 333-206175, File No. 333-210664, 333-214607 and File No. 333-220354) and on Forms S-8 (File No. 333-107438, File No. 333-144265, File No. 333-159282, File No. 333-162733, File No. 333-173854, File No. 333-181365, File No. 333- 184927, File No. 333-191572, File No. 333-205662, File No. 333-212202, File No. 333-215455, File No. 333-218642 and File No. 333-222410).
New York, New York
March 22, 2018